Pathology
Circulating Tumor DNA Associated with Triple-Negative Breast Cancer Recurrence
Patients with early-stage triple-negative breast cancer (TNBC) are frequently treated with neoadjuvant chemotherapy, based on the increased risk for recurrence and death associated with this category of tumors. More...27 Jul 2020
CtDNA Assay for Cancer Recurrence, MRD Applications Demonstrated
Circulating tumor DNA (ctDNA) is found in the bloodstream and refers to DNA that comes from cancerous cells and tumors. Most DNA is inside a cell's nucleus. As a tumor grows, cells die and are replaced by new ones. The dead cells get broken down and their contents, including DNA, are released into the bloodstream. More...22 Jul 2020
Type 2 Diabetes Associated with Arrhythmic Daily Gut Microbe
Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, and unexplained weight loss. More...16 Jul 2020
Early-Onset Preeclampsia Risk Reflected in Circulating Maternal Transcripts
Preeclampsia is a poorly understood pregnancy-associated disorder. Often marked by hypertension, preeclampsia can lead to severe complications including internal bleeding, seizures, stroke, premature birth, and death. More...13 Jul 2020
Rapid Genomic Profiling of Colon Cancers Improves Therapy Selection
Colorectal cancer is a malignant tumor arising from the inner wall of the large intestine (colon) or rectum. Colorectal cancer is the third leading cause of cancer in both men and women in the USA. Most colorectal cancers develop from polyps. Removal of colon polyps can aid in the prevention of colorectal cancer. More...09 Jul 2020
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Tabletop Centrifuge
Mikro 185
In Other News
RNA Sequencing as Alternative to Immunohistochemistry in Cancer Diagnostics
Immune Cells Hampered Fighting Soft Tissue and Bone Sarcomas
Blood Test Could Predict Multiple Sclerosis Progression
Precision Medicine-Based Genetic Testing Developed for Prostate Cancer
Roche Advances Personalized Healthcare with Development of Image Analysis Algorithms Using Artificial Intelligence
Blood Test Predicts Prostate Cancer Treatment Response
Tumor Microbiome Appears to Vary with Cancer Type
Precision Oncology Confers Clinical Benefit in Relapsed Pediatric Cancer
Saliva-Based Assay Developed for HPV-Driven Oropharyngeal Cancer
Representative Tumor Sampling Method Lessens Molecular Analyses Bias
Germline Risk Variants Found in Prostate Cancer Patients
Non-Invasive Blood Assay Can Detect Early Colorectal Cancer
Microcytosis Is a Risk Marker of Cancer in Primary Care
Rare Kidney Cancer Marked by Molecular Features
Blood Test Shows Promise for Predicting Cancer
Bacterial Blood Infections Tied to Heightened Colon Cancer Risk
Multicancer Blood Test Aids Screen for Cancer Guide Intervention
Biomarker Data Improves Risk Prediction for Pancreatic Cancer
Targeted Next-Generation Sequencing Validated for Lysosomal Storage Disorders Diagnosis
Genetic Alterations Analyzed in Pediatric Low-Grade Glioma
Molecular Differences Discovered Among Ovarian Cancer Subgroups
Important Genetic Mechanism Behind Inflammatory Bowel Disease Revealed
Genetic Risk Score Predicts Prostate Cancer Drug Response
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.